Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 11 Apr 2023

Live-attenuated Japanese encephalitis virus inhibits glioblastoma growth and elicits potent antitumor immunity

in Cancer Immunity and Immunotherapy

Zhongbing Qi
Jing Zhao
Yuhua Li
Bin Zhang
Shichuan Hu
Yanwei Chen
Jinhu Ma
Yongheng Shu
Yunmeng Wang
Ping Cheng

Frontiers in Immunology

doi 10.3389/fimmu.2023.982180

3,764 views
4 citations

Original Research

Published on 11 Apr 2023

Camrelizumab plus platinum-irinotecan followed by maintenance camrelizumab plus apatinib in untreated extensive-stage small-cell lung cancer: a nonrandomized clinical trial

in Cancer Immunity and Immunotherapy

Jun Ni
Xiaoyan Si
Hanping Wang
Xiaotong Zhang
Li Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1168879

4,455 views
11 citations

Original Research

Published on 11 Apr 2023

Impact of endogenous glucocorticoid on response to immune checkpoint blockade in patients with advanced cancer

in Cancer Immunity and Immunotherapy

Yu Cui
Xinyue Han
Hongtao Liu
Qi Xie
Yaping Guan
Beibei Yin
Junjuan Xiao
Dongfeng Feng
Xuan Wang
Junwei Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1081790

4,893 views
12 citations

Correction

Published on 11 Apr 2023

Corrigendum: Toxicity profile of combined immune checkpoint inhibitors and thoracic radiotherapy in esophageal cancer: A meta-analysis and systematic review

in Cancer Immunity and Immunotherapy

Tongzhen Xu
Yunsong Liu
Xiaotong Lu
Jun Liang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1193710

1,452 views

Editorial

Published on 11 Apr 2023

Editorial: Community series in novel insights into immunotherapy targeting tumor microenvironment in ovarian cancer: volume I

in Cancer Immunity and Immunotherapy

Xiang-jie Di
Qi Zhao
Hai-tao Wang
Xia-wei Wei
Xiao Liang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1192190

1,853 views
1 citation

Correction

Published on 11 Apr 2023

Corrigendum: Prediction of early treatment response to the combination therapy of TACE plus lenvatinib and anti-PD-1 antibody immunotherapy for unresectable hepatocellular carcinoma: Multicenter retrospective study

in Cancer Immunity and Immunotherapy

Shuqun Li
Junyi Wu
Jiayi Wu
Yangkai Fu
Zhenxin Zeng
Yinan Li
Han Li
Weijia Liao
Maolin Yan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1187423

587 views

Original Research

Published on 11 Apr 2023

Construction of a novel molecular typing and scoring system for anoikis distinguishes between different prognostic risks and treatment responsiveness in low-grade glioma

in Cancer Immunity and Immunotherapy

Ganghua Zhang
Aiyan Chen
Jianing Fang
Anshan Wu
Guanjun Chen
Panpan Tai
Haotian Chen
Xinyu Chen
Ke Cao

Frontiers in Immunology

doi 10.3389/fimmu.2023.1105210

3,178 views
3 citations

Original Research

Published on 11 Apr 2023

Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager

in Cancer Immunity and Immunotherapy

Xinghui Xiao
Ying Cheng
Xiaodong Zheng
Yuhang Fang
Yu Zhang
Rui Sun
Zhigang Tian
Haoyu Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1113303

9,141 views
9 citations

Review

Published on 11 Apr 2023

3D cancer models: One step closer to in vitro human studies

in Cancer Immunity and Immunotherapy

Nicoletta Manduca
Ester Maccafeo
Ruggero De Maria
Antonella Sistigu
Martina Musella

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175503

16,262 views
51 citations

Original Research

Published on 11 Apr 2023

A novel prognostic related lncRNA signature associated with amino acid metabolism in glioma

in Cancer Immunity and Immunotherapy

Qiang Lei
Bo Yuan
Kun Liu
Li Peng
Zhiwei Xia

Frontiers in Immunology

doi 10.3389/fimmu.2023.1014378

3,332 views
6 citations

Editorial

Published on 11 Apr 2023

Editorial: Screening and verification of new targets for CAR-T immunotherapy in cancer

in Cancer Immunity and Immunotherapy

Yang Su
Chen Yuan
Ming Shi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1189773

2,204 views

Original Research

Published on 06 Apr 2023

Amino acid polymorphisms in human histocompatibility leukocyte antigen class II and proinsulin epitope have impacts on type 1 diabetes mellitus induced by immune-checkpoint inhibitors

in Cancer Immunity and Immunotherapy

Hidefumi Inaba
Shuhei Morita
Daisuke Kosugi
Yuki Asai
Yosuke Kaido
Saya Ito
Tomonao Hirobata
Gen Inoue
Yuki Yamamoto
Masatoshi Jinnin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1165004

3,231 views
7 citations

Original Research

Published on 06 Apr 2023

Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Xinyu Ren
Yu Song
Junyi Pang
Longyun Chen
Liangrui Zhou
Zhiyong Liang
Huanwen Wu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1137561

3,698 views
11 citations

Original Research

Published on 06 Apr 2023

A senescence-based prognostic gene signature for colorectal cancer and identification of the role of SPP1-positive macrophages in tumor senescence

in Cancer Immunity and Immunotherapy

Sifei Yu
Mengdi Chen
Lili Xu
Enqiang Mao
Silei Sun

Frontiers in Immunology

doi 10.3389/fimmu.2023.1175490

16,781 views
31 citations

Review

Published on 06 Apr 2023

Role of CD147 in the development and diagnosis of hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Defa Huang
Dingyu Rao
Qing Jin
Mi Lai
Jiali Zhang
Zhonghong Lai
Haibin Shen
Tianyu Zhong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1149931

6,706 views
22 citations

Original Research

Published on 06 Apr 2023

A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes

in Cancer Immunity and Immunotherapy

Haijun Tang
Shangyu Liu
Xiaoting Luo
Yu Sun
Xiangde Li
Kai Luo
Shijie Liao
Feicui Li
Jiming Liang
Xinli Zhan

Frontiers in Immunology

doi 10.3389/fimmu.2023.1150588

3,851 views
8 citations